SE8405615D0 - Sustained release pharmaceutical tablets and process for the preparation thereof - Google Patents

Sustained release pharmaceutical tablets and process for the preparation thereof

Info

Publication number
SE8405615D0
SE8405615D0 SE8405615A SE8405615A SE8405615D0 SE 8405615 D0 SE8405615 D0 SE 8405615D0 SE 8405615 A SE8405615 A SE 8405615A SE 8405615 A SE8405615 A SE 8405615A SE 8405615 D0 SE8405615 D0 SE 8405615D0
Authority
SE
Sweden
Prior art keywords
active ingredient
sustained release
manufacturing
weight
retardizing
Prior art date
Application number
SE8405615A
Other languages
English (en)
Other versions
SE455571B (sv
SE8405615L (sv
Inventor
D Bezzegh
P Fekete
Z Toth
I Bor
E Fellner
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE8405615D0 publication Critical patent/SE8405615D0/sv
Publication of SE8405615L publication Critical patent/SE8405615L/sv
Publication of SE455571B publication Critical patent/SE455571B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8405615A 1983-11-11 1984-11-09 Farmaceutiska tabletter med depaverkan och forfarande for deras framstellning SE455571B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU833859A HU190619B (en) 1983-11-11 1983-11-11 Process for producing tablets with controlled dissolution of active ingredients

Publications (3)

Publication Number Publication Date
SE8405615D0 true SE8405615D0 (sv) 1984-11-09
SE8405615L SE8405615L (sv) 1985-05-12
SE455571B SE455571B (sv) 1988-07-25

Family

ID=10965801

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8405615A SE455571B (sv) 1983-11-11 1984-11-09 Farmaceutiska tabletter med depaverkan och forfarande for deras framstellning

Country Status (15)

Country Link
US (1) US4647599A (sv)
JP (1) JPH0751497B2 (sv)
AT (1) AT391078B (sv)
BE (1) BE901007A (sv)
CH (1) CH665124A5 (sv)
DD (1) DD229030A5 (sv)
DE (1) DE3441308C2 (sv)
FI (1) FI78614C (sv)
FR (1) FR2554717B1 (sv)
GB (1) GB2149413B (sv)
HU (1) HU190619B (sv)
NL (1) NL8403447A (sv)
SE (1) SE455571B (sv)
SU (1) SU1577684A3 (sv)
UA (1) UA5328A1 (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2201594B (en) * 1986-06-24 1991-02-13 Istvan Racz Production of acid binding pharmaceutical preparations
HU196711B (en) * 1986-06-24 1989-01-30 Istvan Racz Process for producing long-acting, gastric acid neutralizing pharmaceutics with high acid-binding capacity and increased bioavailability
US4844908A (en) * 1986-11-27 1989-07-04 Duphar International Research B.V. Method of preparing tablets with clovoxamine fumarate and tablets thus prepared
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US4961932A (en) * 1987-10-26 1990-10-09 Alza Corporation Plurality of tiny pills in liquid dosage form
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US4971804A (en) * 1989-02-02 1990-11-20 Warner-Lambert Company Water dispersible gemfibrozil compositions
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
ES2061394B1 (es) * 1993-02-05 1995-06-16 Robert S A Lab Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada.
JP3732557B2 (ja) * 1995-07-12 2006-01-05 住友精化株式会社 カルボキシル基含有重合体組成物
US6492488B1 (en) * 1998-08-02 2002-12-10 Pmd Holdings Corp. Controlled release polyacrylic acid granules and a process for preparing the same
DE19836646A1 (de) * 1998-08-13 2000-02-17 Basf Ag Verwendung von N-Vinylpyrrolidon- und Vinylacetat-haltigen Copolymeren als Matrix zur Herstellung von festen, oralen pharmazeutischen und kosmetischen Zubereitungen
KR100407519B1 (ko) * 2001-08-31 2003-12-18 부광약품 주식회사 건조황산제일철과 방출조절제로서 엘-글루타민을 함유하는서방성 정제 및 그의 제조방법
CA2534039A1 (en) * 2003-08-19 2005-03-03 Polybiomed Limited Polymeric drug release system for medical devices
US7846466B2 (en) * 2004-06-10 2010-12-07 Northwestern University Biodegradable scaffolds and uses thereof
JP5826456B2 (ja) * 2006-04-26 2015-12-02 アルファファーム ピーティーワイ リミテッド コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物
GB0707127D0 (en) * 2007-04-13 2007-05-23 Zysis Ltd Pharmaceutical compositions
AR083150A1 (es) 2010-05-10 2013-02-06 Euro Celtique Sa Composiciones farmaceuticas que comprenden hidromorfona y naloxona
CA2798884C (en) * 2010-05-10 2016-09-13 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
BR112015003733A2 (pt) * 2012-08-23 2017-07-04 Cardiolynx Ag composições de liberação estendida de um nitrato de aminoalquila
DE112014005175T5 (de) 2013-11-13 2016-07-21 Euro-Celtique S.A. Hydromorphon und Naloxon für die Behandlung von Schmerzen und Opioid-Darm-Dysfunktions-Syndrom

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) * 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
SE353229B (sv) * 1970-06-04 1973-01-29 Haessle Ab
FR2247206B1 (sv) * 1973-01-24 1978-02-03 Sterwin Ag
US3851032A (en) 1973-04-23 1974-11-26 Sterling Drug Inc Process of preparing a solid fine crystalline paracetamol polymer complex composition
US3923974A (en) * 1973-04-23 1975-12-02 Sterling Drug Inc Solid fine crystalline paracetamol polymer complex composition
CA1097220A (en) * 1975-10-10 1981-03-10 Aaron L. Weiss Controlled release tablet
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
HU183408B (en) * 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method

Also Published As

Publication number Publication date
FR2554717A1 (fr) 1985-05-17
DE3441308C2 (de) 1994-03-31
DE3441308A1 (de) 1985-05-23
NL8403447A (nl) 1985-06-03
DD229030A5 (de) 1985-10-30
ATA355084A (de) 1990-02-15
FI78614B (fi) 1989-05-31
JPS60222413A (ja) 1985-11-07
BE901007A (fr) 1985-05-08
US4647599A (en) 1987-03-03
SE455571B (sv) 1988-07-25
GB2149413B (en) 1987-04-08
FI78614C (sv) 1989-09-11
JPH0751497B2 (ja) 1995-06-05
GB8428369D0 (en) 1984-12-19
HUT34892A (en) 1985-05-28
UA5328A1 (uk) 1994-12-28
SU1577684A3 (ru) 1990-07-07
FR2554717B1 (fr) 1988-05-13
HU190619B (en) 1986-09-29
AT391078B (de) 1990-08-10
CH665124A5 (de) 1988-04-29
SE8405615L (sv) 1985-05-12
FI844405L (fi) 1985-05-12
GB2149413A (en) 1985-06-12
FI844405A0 (fi) 1984-11-09

Similar Documents

Publication Publication Date Title
SE8405615D0 (sv) Sustained release pharmaceutical tablets and process for the preparation thereof
DE3887179D1 (de) Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
ES8502333A1 (es) Un procedimiento para la preparacion de una tableta farmaceutica
NO971965L (no) Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav
ATE37788T1 (de) Arzneimittel und verfahren zu ihrer herstellung.
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
KR880009639A (ko) 서방성 매트릭스 제형
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE68695T1 (de) Teilchen aus einer hydrophoben oder schwerloeslichen substanz und verfahren zu ihrer hydrophilisierung.
IE821361L (en) Diamionic 5, 5'-azobis-salicylic acid composition
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
ATE20517T1 (de) Theophyllintablette mit kontrollierter wirkstoffabgabe und verfahren zu deren herstellung.
ATE24933T1 (de) Biologisch wirksame verbindungen ws 6049, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
PT79786A (fr) Procede de preparation d'1ne matrice inerte a base de polycaprolactone pour administration orale d'un medicament
DE04078149T1 (de) Stabile feste Zusammensetzung von Enalaprilsalz und dessen Herstellung
AU566228B2 (en) Compressed hydroxybutryic acid polymer retarded release vehicle
ES8101070A1 (es) Procedimiento para la obtencion de 11-alquilen-morfantridi- nas 6-sustituidas
PT84526B (pt) Processo para a preparacao de uma composicao solida compreendendo granulos consistindo essencialmente de um agregado de cristais de ibuprofeno
ATE121936T1 (de) Isosorbide-5-mononitrate enthaltende tablette mit verzögerter abgabe und verfahren zu ihrer herstellung.
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
FR2648132B1 (fr) Composes pigmentogenes, leurs vehicules de diffusion, compositions les contenant et leur procede de preparation
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
JPS5759815A (en) Drug composition having preventing and remedying action on rotavirus infectious disease
SE8802480D0 (sv) Method of preparation of nucleic acid derivatives and method of preparation of medical composition containing the same
PL237105A1 (en) Acaricide and method of manufacturing the same

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8405615-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8405615-9

Format of ref document f/p: F